Published in Healthcare Finance, Tax and Law Weekly, May 13th, 2009
“Acacia Research executed $16,350,000 in licensing transactions in the first quarter of 2009, resulting in first quarter license fee revenues of $12,650,000, an increase of 40%, compared to $9,048,000 in the year ago period, and prepaid deferred revenues of $3,700,000 which will be recognized as revenues in subsequent periods. Cash and investments increased during the quarter by $2,483,000 to $54,001,000,” commented Acacia Research Chairman and CEO, Paul Ryan.
“Acacia Research trailing 12-month revenues were $51,829,000, an increase of 42%, compared...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.